Increasing the predictive value of preclinical studies.
Biomarkers are distinctive biological characteristics that can predict pathology early in disease as well as enhance mechanistic understanding of disease. Biomarkers are useful in preclinical studies since they are objectively measured as an indication of normal biological processes, pathogenic processes, or pharmacological responses to therapeutic treatments. Utilizing clinically relevant biomarkers in preclinical studies enhances the predictive value of the data.
Example Flow Cytometry Analysis
CD4, Th1, Th17, Treg were anlayzed in spleen and spinal cord samples from a mouse MOG-EAE study.
Ready to discuss your project?
If you are ready to discuss how electrophysiology can add to your understanding of your therapeutic potential, our scientists are eager to explore the possibilities with you. Like many other pharmaceutical and medical device developers, you can rely on predictive preclinical data.